Analyst Consensus
- Current Price
- 411.35 $
- Target (Low)
- 215.88 $
- Target (Mean)
- 523.84 $
- Target (High)
- 650.00 $
- Recommendation
- Strong Buy
- Number of Analysts
- 45
Recommendation Distribution
Recommendation Distribution| Strong Buy | 8 |
|---|
| Buy | 36 |
|---|
| Hold | 4 |
|---|
| Sell | 0 |
|---|
| Strong Sell | 0 |
|---|
Key Ratios
- Net Profit Margin
- 38.8%
- Operating Margin
- 49.0%
- Gross Margin
- 76.3%
- Return on Equity (ROE)
- 37.3%
- Return on Assets (ROA)
- 12.1%
- Revenue Growth
- 47.9%
- Earnings Growth
- 85.4%
- Debt/Equity
- 74.02
- Current Ratio
- 2.24
- Beta
- 1.43
Recent Rating Changes
Recent Rating Changes| Date | Firm | Change |
|---|
| Jun 4, 2026 | UBS | Buy → Buy |
| Jun 4, 2026 | B of A Securities | Buy → Buy |
| Jun 4, 2026 | Mizuho | Outperform → Outperform |
| Jun 4, 2026 | Oppenheimer | Outperform → Outperform |
| Jun 4, 2026 | Macquarie | Outperform → Neutral |
| Jun 4, 2026 | JP Morgan | Overweight → Overweight |